Cancer therapeutics based on diverse energy sources
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Son, Subin | - |
dc.contributor.author | Kim, Jungryun | - |
dc.contributor.author | Kim, Jaewon | - |
dc.contributor.author | Kim, Byungkook | - |
dc.contributor.author | Lee, Jieun | - |
dc.contributor.author | Kim, Yuri | - |
dc.contributor.author | Li, Mingle | - |
dc.contributor.author | Kang, Heemin | - |
dc.contributor.author | Kim, Jong Seung | - |
dc.date.accessioned | 2022-11-17T20:40:38Z | - |
dc.date.available | 2022-11-17T20:40:38Z | - |
dc.date.created | 2022-11-17 | - |
dc.date.issued | 2022-10-03 | - |
dc.identifier.issn | 0306-0012 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/145676 | - |
dc.description.abstract | Light-based phototherapy has been developed for cancer treatment owing to its non-invasiveness and spatiotemporal control. Despite the unique merits of phototherapy, one critical disadvantage of light is its limited penetration depth, which restricts its application in cancer treatment. Although many researchers have developed various strategies to deliver light into deep-seated tumors with two-photon and near-infrared light irradiation, phototherapy encounters the peculiar limitations of light. In addition, high oxygen dependency is another limitation of photodynamic therapy to treat hypoxic tumors. To overcome the drawbacks of conventional treatments, various energy sources have been developed for cancer treatment. Generally, most energy sources, such as ultrasound, chemiluminescence, radiation, microwave, electricity, and magnetic field, are relatively free from the restraint of penetration depth. Combining other strategies or therapies with other energy-source-based therapies improves the strength and compensates for the weakness. This tutorial review focuses on recent advances in the diverse energy sources utilized in cancer treatment and their future perspectives. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ROYAL SOC CHEMISTRY | - |
dc.subject | PHOTODYNAMIC THERAPY | - |
dc.subject | PHOTOTHERMAL THERAPY | - |
dc.subject | GOLD-NANORODS | - |
dc.subject | HYPERTHERMIA | - |
dc.subject | NANOPARTICLES | - |
dc.subject | IRRADIATION | - |
dc.subject | TUMORS | - |
dc.subject | DEPTH | - |
dc.title | Cancer therapeutics based on diverse energy sources | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kang, Heemin | - |
dc.contributor.affiliatedAuthor | Kim, Jong Seung | - |
dc.identifier.doi | 10.1039/d2cs00102k | - |
dc.identifier.scopusid | 2-s2.0-85138648463 | - |
dc.identifier.wosid | 000850629000001 | - |
dc.identifier.bibliographicCitation | CHEMICAL SOCIETY REVIEWS, v.51, no.19, pp.8201 - 8215 | - |
dc.relation.isPartOf | CHEMICAL SOCIETY REVIEWS | - |
dc.citation.title | CHEMICAL SOCIETY REVIEWS | - |
dc.citation.volume | 51 | - |
dc.citation.number | 19 | - |
dc.citation.startPage | 8201 | - |
dc.citation.endPage | 8215 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | PHOTODYNAMIC THERAPY | - |
dc.subject.keywordPlus | PHOTOTHERMAL THERAPY | - |
dc.subject.keywordPlus | GOLD-NANORODS | - |
dc.subject.keywordPlus | HYPERTHERMIA | - |
dc.subject.keywordPlus | NANOPARTICLES | - |
dc.subject.keywordPlus | IRRADIATION | - |
dc.subject.keywordPlus | TUMORS | - |
dc.subject.keywordPlus | DEPTH | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.